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broaden our ability to look into the poorly explored field of the
coronary microcirculation.
SAMUEL ZONERAICH, MD, FACC
Long Island Jewish-Hillside Medical Center
State University of New York at Stony Brook
Queens Hospital Center Affiliation
82-68 164th Street
Jamaica. New York 11432
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Angina Caused by Reduced Vasodilator
Reserve of the Small Coronary Arteries.
III: Study Design
As an observer of the passing scene of "atypical chest pain,"
I cannot but be impressed with the multiplicity of claims as to its
cause: spasm, thromboemboli, small vessel disease. impaired me-
tabolism, myocardial bridging, and so on. Theories and articles
"proving" such theories appear every year, exist for a period of
time. are quoted extensively on ward rounds and the like and then
usually silently slip into either oblivion or irrelevancy. Before this
happens, however, thousands of patients are misclassified. cardiac
neuroses are accentuated or supported and hundreds of thousands
of research dollars are spent in either attempting to corroborate or
negate the results, all in the alleged interest of "science."
In the article by Cannon et al., I am concerned about the
inadequately small numbers of patients studied. premature pub-
lication of data and inadequate experimental design. Where. for
instance. are the data to show that the control subjects at the
National Institutes of Health actually do not have the same type
of response as was found in the patients with atypical chest pain?
Other potential flaws include: 1) the tremendous overlap in the
data, with an interpretation by the authors that most conveniently
fits the hypothesis, and 2) the possibility that statistically significant
differences may not have any biologic significance.
Though this letter may seem unreasonably critical, it is merely
stated as it is in order to make a plea to all of us, and especially
leaders in medical research, to try and reach some level of sen-
sibility, balance and judgment in research and publications.
KEITH COHN, MD, FACC
Clinical Professor of Medicine
University of California. San Francisco
Co-Director. Division of Cardiology
Pacific Medical Center
P.O. Box 7999
San Francisco. California 94120
Reply
I
Hellstrom draws attention to the possible role of myocardial
resistance vessels as mediators of ischemia and infarction (1). Our
study does strongly suggest that vasoconstrictor stimuli are capable
of either limiting physiologically appropriate arteriolar vasodilation
in response to increases in MVOz or provoking actual vasocon-
striction at rest, resulting in myocardial ischemia and angina. Quite
likely, such responses also account for many of the atypical fea-
tures of chest pain often found in patients with coronary athero-
sclerosis. Our data also suggest that small vessel vasoconstriction
can cause myocardial infarction, in that several of our patients
(who had no significant epicardial fixed obstructive disease or
spasm) had myocardial infarction, as evidenced by history or by
wall motion abnormalities detected by contrast or radionuclide
ventriculography.
However, central to Hellstrom's hypothesis is the primary role
of resistance vessel spasm in the genesis of myocardial ischemia
or infarction, or both, even in the presence of severe coronary
atherosclerosis or epicardial coronary spasm. Hellstrom also be-
lieves that small and large coronary arteries are similar, both in
terms of anatomy and innervation, and that large and small vessel
spasm are therefore necessarily manifestations of a single patho-
physiologic entity. A natural extension of this is his belief that all
cases of Prinzmetal's angina are caused by spasm of resistance
vessels, with large vessel spasm being clinically irrelevant and
representing only a reflex response to the primary small vessel
change.
In regard to these hypotheses, our data do suggest that resistance
vessels can constrict in the face of an ischemic (and therefore
vasodilator) stimulus. However, we would at this time not ascribe
to Hellstrom's unifying hypothesis, which assigns the central causal
role of myocardial ischemia and infarction to the resistance vessels
in all instances. It is clear that the physiologic response and neural
innervation of the epicardial and resistance vessels are different
(2); we also believe there is ample evidence demonstrating that
large vessel spasm can be profound enough to be primarily re-
sponsible for the precipitation of ischemia (3). Although spasm of
the resistance vessels may coexist, there is no evidence at this time
suggesting that large vessel spasm must necessarily be relegated
to a clinically irrelevant role, occurring only reflexly as a result
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of small vessel spasm. We also believe that although spasm of
resistance vessels may. in certain instances, contribute to the extent
of ischemic injury occurring in patients with coronary artery dis-
ease experiencing an acute infarction, the evidence is overwhelm-
ing that large vessel obstruction is of paramount importance. Thus,
while our study does suggest an important independent role of
myocardial resistance vessels in the cause of myocardial ischemia
and infarction, it does not directly support Hellstrom's interesting
but highly speculative hypothesis.
II
Zoneraich raises the possibility of morphologically abnormal
arteriolar vessels, as has been described in some, but not all,
patients with diabetes mellitus (4,5). The three diabetic patients
in our series demonstrated a broad spectrum of coronary flow
responses. One patient (Patient 16) demonstrated significant in-
creases in coronary flow without chest pain in the control, cold
pressor and ergonovine studies with simultaneous pacing. Patient
17, although demonstrating a normal flow response during the
control pacing and cold pressor test studies, was found to have
limited vasodilator reserve associated with chest pain and de-
creased lactate consumption during the ergonovine study. Patient
8 demonstrated limited vasodilator reserve, decreased lactate con-
sumption and chest pain during the control and cold pressor test
studies. No other patient in the study demonstrated an elevated
fasting blood sugar. Thus, no obvious association between ab-
normal vasodilator reserve and diabetes mellitus can be made from
this small group.
However, the absence of myocardial biopsy information con-
cerning small vessel pathology makes further discussion about the
role of fixed small vessel disease speculative only. Two points
deserve mention. Another study (6) of patients with chest pain and
"normal" coronary arteries in which myocardial biopsies were
performed reported no small vessel morphologic abnormalities.
Second, fixed small vessel disease in our study would not explain
the dynamic features of the coronary flow responses, that is, in-
appropriate vasodilator reserve or active vasoconstriction un-
masked or exacerbated by vasoconstrictor stimuli. The two hy-
potheses of small vessel disease (fixed versus dynamic) may not
be mutually exclusive. Some diabetic patients may have elements
of both phenomena.
III
Although we have considered all of Cohn's comments, we
have, with great forbearance, limited our response to his questions
regarding the science of our study. Cohn expresses concern about
the absence of true control subjects in our study (that is, healthy
subjects not complaining of chest pain). Ethical considerations
prohibit participation of such a population in an extensive invasive
study that carries a risk of morbidity and mortality, albeit small.
Nonetheless. patients experiencing their typical chest pain during
this study clearly differed in their coronary circulatory response
to pacing and vasoconstrictor stimuli from those patients not ex-
periencing pain during the study. We believe the patients not
experiencing pain can be considered a reasonable control group.
Although the number of patients may seem small to Cohn, the
demonstration of limited vasodilator reserve, especially when, after
ergonovine. there is essentially no overlap of data, was impressive.
We have now studied over 50 patients using the same protocol,
and the same observations made in our initial study have been
noted in this larger group. The hypothesis of abnormal vasodilator
reserve of small coronary arteries, presumably arterioles, is rea-
sonably supported by the data, and has been suggested by others
(6). Our study shows that this abnormality is dynamic and may
be unmasked or exacerbated by vasoconstrictor stimuli. That our
findings are biologically significant is strongly suggested by the
observation that vasoconstnctor stimuli not only produce the pa-
tient's typical chest pain, but that the pain is associated with lim-
ttation of coronary blood flow and abnormal lactate metabolism,
Cohn, in his remarks, Implies the obvious: that studies should
not be published until they satisfy the criteria established for good
science. The perception of what these criteria are may vary from
one scientist to another, and we cannot bear responsibility for other
studies on atypical chest pain to which Cohn refers and which
have not withstood the test of time. However. it is our opinion
(and that of two reviewers, the editors of lACC and the authors
of an editorial accompanying our study) that our findings are im-
portant and merit publication.
More studies are clearly needed to clarify the mechanism of
angina in these patients. For the present, "small vessel spasm"
and" inappropriate small vessel vasodilator reserve" must be con-
sidered tentative hypotheses. We hope our work will stimulate
further investigation in this possibly common and important man-
ifestation of angina pectoris.
RICHARD O. CANNON. III, MD
STEPHEN E. EPSTEIN. MD, FACC
National Heart, Lung, and Blood Institute
Cardiology Branch
9000 Rockville Pike
Bethesda. Maryland 20205
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Anterior Transmural Myocardial Infarction:
Controlled Randomized Studies
DeWood and colleagues (I) have contributed a technically ex-
cellent, well written and therapeutically promising study of surgical
reperfusion during acute myocardial infarction. While the authors
did not begin scientifically-with an appropriately designed. ran-
domized trial (2)-they have made two separate declarations (both
on page 1232) indicating I) that they understand that uncontrolled,
nonrandomized studies could introduce bias, and 2) that "a con-
